Psoriatic arthritis is a type of inflammatory arthritis ... Biosimilars are biologic therapies very similar to already approved biologic drugs. You can recognize them by the way their names ...

The study grouped 32,098 patients with psoriasis or psoriatic arthritis (PsA) into their respective categories based on biologic treatment, which included TNFi (n = 20,314), IL-17i (n = 5,073), IL ...

Biologics are given by injection or infusion. There are several categories of these drugs: Acthar gel (repository ... for ...

Nevertheless, 68% of the $3.5 billion global psoriasis market is captured by biologic therapies; topical agents and conventional systemic drugs account for ∼25% and ∼7%, respectively.

The FDA has accepted Alvotech (ALVO) and Teva's (TEVA) applications for AVT05, their proposed biosimilar to J&J's ...

Treating your rheumatoid arthritis with a biologic drug has probably been pretty effective. Biologics are designed to target inflammation and stop joint damage like a sniper in the war against RA.

In recent years, there's been a revolution in Disease-Modifying Antirheumatic Drugs ... have a look at how biologics work to help correct it. ALLAN GIBOFSKY: In rheumatoid arthritis, a person's ...

Topline data were announced from two phase 3 trials evaluating deucravacitinib, a tyrosine kinase 2 (TYK2) inhibitor, in adults with active psoriatic ... biologic disease-modifying antirheumatic ...

In a large cohort of patients with autoimmune diseases, treatment with biologic disease-modifying antirheumatic drugs was ...

Rheumatoid arthritis (RA ... Special discount programmes are available for each of the biologic DMARDs, but the high cost of these drugs limits access in the United States and elsewhere.